» Articles » PMID: 30155405

Extracellular Vesicles-mediated Signaling in the Osteosarcoma Microenvironment: Roles and Potential Therapeutic Targets

Overview
Journal J Bone Oncol
Publisher Elsevier
Date 2018 Aug 30
PMID 30155405
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Osteosarcoma (OS) is the most common non-hematologic malignant tumor of bone in children. It is usually characterized by a high risk of developing lung metastasis and poor prognosis. Extracellular vesicles (EVs) are cell-derived nanoparticles with a small size of 50-200 nm in diameter. As a communicator, the contents of the EVs secreted via either fusing with lysosomes for degradation and recycling or fusing with the cell plasma membrane into the extracellular environment, which play an important role in regulating the tumor microenvironment of OS and mediating the Wnt/β-catenin and TGF-β signalings. Increasing evidences suggest that EVs have significant role in OS growth, progression, metastasis and drug resistance. In this study, the roles of EVs in the physiology and pathogenesis of OS and the potential attractive therapeutic target for the treatment of OS were reviewed.

Citing Articles

Extracellular vesicle: A magic lamp to treat skin aging, refractory wound, and pigmented dermatosis?.

Wu H, Zhang Z, Zhang Y, Zhao Z, Zhu H, Yue C Front Bioeng Biotechnol. 2022; 10:1043320.

PMID: 36420445 PMC: 9676268. DOI: 10.3389/fbioe.2022.1043320.


Dose-related shifts in proteome and function of extracellular vesicles secreted by fetal neural stem cells following chronic alcohol exposure.

Chung D, Pinson M, Mahnke A, Salem N, Le K, Payne E Heliyon. 2022; 8(11):e11348.

PMID: 36387439 PMC: 9649983. DOI: 10.1016/j.heliyon.2022.e11348.


Liquid biopsies in primary and secondary bone cancers.

Ucci A, Rucci N, Ponzetti M Cancer Drug Resist. 2022; 5(3):541-559.

PMID: 36176757 PMC: 9511800. DOI: 10.20517/cdr.2022.17.


Role of extracellular vesicles in osteosarcoma.

Yang Q, Liu J, Wu B, Wang X, Jiang Y, Zhu D Int J Med Sci. 2022; 19(8):1216-1226.

PMID: 35928720 PMC: 9346389. DOI: 10.7150/ijms.74137.


Extracellular vesicles from bone mesenchymal stem cells transport microRNA-206 into osteosarcoma cells and target NRSN2 to block the ERK1/2-Bcl-xL signaling pathway.

Keremu A, Aila P, Tusun A, Abulikemu M, Zou X Eur J Histochem. 2022; 66(3).

PMID: 35730574 PMC: 9251612. DOI: 10.4081/ejh.2022.3394.


References
1.
Zhang X, Yuan X, Shi H, Wu L, Qian H, Xu W . Exosomes in cancer: small particle, big player. J Hematol Oncol. 2015; 8:83. PMC: 4496882. DOI: 10.1186/s13045-015-0181-x. View

2.
Raimondo S, Saieva L, Corrado C, Fontana S, Flugy A, Rizzo A . Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism. Cell Commun Signal. 2015; 13:8. PMC: 4320527. DOI: 10.1186/s12964-015-0086-x. View

3.
Lim P, Bliss S, Patel S, Taborga M, Dave M, Gregory L . Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res. 2011; 71(5):1550-60. DOI: 10.1158/0008-5472.CAN-10-2372. View

4.
Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D . Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998; 4(5):594-600. DOI: 10.1038/nm0598-594. View

5.
Chen C, Zhao M, Tian A, Zhang X, Yao Z, Ma X . Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cells. Oncotarget. 2015; 6(19):17570-83. PMC: 4627329. DOI: 10.18632/oncotarget.4100. View